Document:

Amendment Number One to the 2006 Stock Option and Restricted Stock Plan

 Exhibit 10.3 
 AMENDMENT NUMBER ONE 
 TO THE 
 CELLU PARENT CORPORATION 
 2006 STOCK OPTION AND RESTRICTED STOCK PLAN 
 Pursuant to Section 9 of
the Cellu Parent Corporation (“Corporation”) 2006 Stock Option and Restricted Stock Plan (“Plan”), the Corporation hereby adopts this Amendment Number One to evidence the action of the Board of Directors of the Corporation
approving the following amendment to the Plan: 
 §1 
 By amending the first sentence of Section 4(a) to reflect the increase in the number of shares under the Plan, to read as follows:

 “A maximum of 12,095 shares of Stock may be delivered in satisfaction of Awards under the Plan.” 
 §2 
 Except as
otherwise expressly amended by this Amendment, all the provisions of the Plan shall remain in full force and effect. 
 IN WITNESS WHEREOF, the Corporation has caused this Amendment Number One to be executed by its duly authorized officer as of this 2nd day of April, 2009. 
  

			
	CELLU PARENT CORPORATION
		
	By:	 	 /s/ W. Edwin Litton

	Title:	 	 General Counsel/SecretaryAmendment Number Two to the 2006 Stock Option and Restricted Stock Plan

 Exhibit 10.4 
 AMENDMENT NUMBER TWO 
 TO THE CELLU PARENT
CORPORATION 
 2006 STOCK OPTION AND RESTRICTED STOCK PLAN 
 Pursuant to Section 9 of the Cellu Parent Corporation (“Corporation”) 2006 Stock Option and Restricted Stock Plan
(“Plan”), the Corporation hereby adopts this Amendment Number Two to evidence the action of the Board of Directors of the Corporation approving the following amendment to the Plan: 
 § 1 
 By adding a new Section 12, IPO
Vesting and Put Right, to read as follows: 
 Effective upon the consummation of the initial public offering of the common
stock of Cellu Tissue Holdings, Inc. (“CT”) as described in the Registration Statement on Form S-1 (No. 333-162543) (the “Registration Statement”) filed with the Securities and Exchange Commission on October 16, 2009,
as amended from time to time (the “IPO”), (1) each Participant listed on Exhibit A to this Amendment (“Exhibit A Participant”) shall (upon consummation of the IPO) be deemed to have satisfied in full any performance-based
vesting condition (but not any time-based vesting conditions not otherwise satisfied as of the consummation of the IPO) for the Stock Options listed for such Exhibit A Participant on Exhibit A, (2) each Participant listed on Exhibit B to
this Amendment (“Exhibit B Participant”) and Stan Trevisan shall be eligible to exercise any Stock Options that are vested on or prior to the consummation of the IPO (“Vested Options”) pursuant to the terms of the applicable
Stock Option agreement using the cashless exercise program approved by the Administrator for this purpose, (3) each Exhibit B Participant who exercises his or her Vested Options during the three business days following the distribution
completion date of the IPO as defined under Regulation M (which shall be determined by CT) (such period, the “Put Period”)

 
will have the right at the time of such exercise to put to CT the shares of stock transferable upon such exercise (the “Transferable Shares”) (less any shares applied to satisfy the
exercise price or any applicable tax withholding) subject to the terms and conditions of this Section 12, (4) this right to put the Transferable Shares to CT (the “Put Right”) shall be effected at the initial public offering
price per share set forth on the cover of the final prospectus forming part of the Registration Statement (“IPO Price”) and shall be limited to the percentage of the Transferable Shares that is equal to the percentage of the total number
of shares of CT common stock held by Weston Presidio (following the conversion of any shares of the Corporation in connection with the IPO) that Weston Presidio sells in the IPO on the initial closing date of the IPO, (5) for any Exhibit B
Participant who elects to exercise his or her Vested Options using the cashless exercise program and to exercise the Put Right, the shares applied to satisfy the exercise price (and to satisfy any applicable tax withholding) will be treated as
having a fair market value equal to the IPO Price. The Administrator shall have the power to establish such procedures as the Administrator deems appropriate to effect this Section 12. If the IPO is not consummated, this Section 12 shall
be null and void ab initio. 
 § 2 
 Except as otherwise expressly amended by this Amendment, all the provisions of the Plan shall remain in full force and effect. 
 IN WITNESS WHEREOF, the Corporation has caused this Amendment Number Two to be executed by its duly authorized
officer as of this 27th day of January, 2010. 

 

					
	CELLU PARENT CORPORATION
		
	By:	 	 /s/ Russell C. Taylor

		 	Name:	 	Russell C. Taylor
		 	Title:	 	President

  

 2 

 Exhibit A 
 Participants Vested in Performance Based Options 
  

					
	 Name of Option Holder
	  	APF Performance Option
Grant Date
	  	Unvested APF Performance
Options Subject to
Full Vesting
	 1. Bambi Gorman
	  	4/13/09	  	71
			
	 2. Stan Trevisan
	  	4/13/09	  	104
			
	 3. D’Arcy Schnekenburger
	  	4/13/09	  	156
			
	 4. Eddie Litton
	  	4/13/09	  	83
			
	 5. Gregory P. Destiche
	  	4/13/09	  	65
			
	 6. Gregory McNulty
	  	4/13/09	  	71
			
	 7. Katherine Hendricks
	  	4/13/09	  	32
			
	 8. Laura Luhm
	  	4/13/09	  	187
			
	 9. Michael Roache
	  	4/13/09	  	52
			
	 10. A. Michael Barsevich
	  	4/13/09	  	71
			
	 11. Anthony Sanders
	  	4/13/09	  	52

 Exhibit B 
 Participants Eligible for Put Right 
 A. Michael Barsevich 

Umberto DeCal 
 Gregory P. Destiche 

Christopher R. Fiedler 
 Kevin M. French

 Maria Lana Graham 
 Bambi Gorman

 Katherine Hendricks 
 Eddie Litton

 Laura Luhm 
 John McGrath 

Gregory McNulty 
 Stephen Michalko 
 Michael Roache 
 Anthony Sanders 
 Keith Schenk 
 D’Arcy Schnekenburger

 Deborah SwensonAmendment to Employment Agreement, Russell C. Taylor

 Exhibit 10.5 
 AMENDMENT TO EMPLOYMENT AGREEMENT 
 This Amendment is made
and entered into as of January 18, 2010 by and between Cellu Tissue Holdings, Inc. (the “Company”) and Mr. Russell Taylor (the “Executive”) effective as of the date set forth herein. 
 WHEREAS, the Company and the Executive entered into an agreement regarding the terms of the Executive’s employment with the Company
(the “Employment Agreement”) effective as of the Closing Date, as defined in the Agreement and Plan of Merger dated May 8, 2006 by and among Cellu Parent Corporation, Cellu Acquisition Corporation, and Cellu Paper Holdings, Inc.,
which was June 12, 2006 (the “Effective Date”); 
 WHEREAS, the Company anticipates completing an initial public
offering of the common stock of the Company as described in the Registration Statement on Form S-1 (No. 333-162543) (the “Registration Statement”) filed with the Securities and Exchange Commission on October 16, 2009, as amended from
time to time (the “IPO”); 
 WHEREAS, in connection with the IPO, the Company and the Executive desire to amend the
Employment Agreement as set forth in this Amendment effective upon the consummation of the IPO; 
 NOW, THEREFORE, in
consideration of the foregoing premises and the terms set forth in this Amendment, the parties hereby agree as follows effective upon the consummation of the IPO: 
 1. The initial term of the Employment Agreement as set forth in Section 2 of such agreement (which would have expired on June 12, 2010) is hereby extended through June 12, 2011. Except for
this one year extension, the provisions of Section 2 of the Employment Agreement shall continue in full force and effect. 
 2. Section 4(b) of the Employment Agreement is hereby deleted and replaced with the following provision: 
 Executive shall be eligible to receive an annual bonus. Commencing with the 2011 fiscal year, the annual bonus shall be determined by the Compensation Committee of the Board (or a subcommittee of the Compensation Committee) based upon the
Executive’s achievement of performance goals established by such committee, and such annual bonus shall at all times be subject to the terms of the Company’s Annual Executive Bonus Program, as amended from time to time. 
 IN WITNESS WHEREOF, the Company and the Executive have executed this Amendment this 18 day of January, 2010. 
  

									
	CELLU TISSUE HOLDINGS, INC.	 		 		 	EXECUTIVE
					
	By:	 	/s/ W. Edwin Litton	 		 		 	/s/ Russell C. TaylorAmendment to Employment Agreement, Steven D. Ziessler

 Exhibit 10.6 
 AMENDMENT TO EMPLOYMENT AGREEMENT 
 This Amendment is made
and entered into as of January 18, 2010 by and between Cellu Tissue Holdings, Inc. (the “Company”) and Mr. Steven Ziessler (the “Executive”) effective as of the date set forth herein. 
 WHEREAS, the Company and the Executive entered into an agreement regarding the terms of the Executive’s employment with the Company
(the “Employment Agreement”) effective as of the Closing Date, as defined in the Agreement and Plan of Merger dated May 8, 2006 by and among Cellu Parent Corporation, Cellu Acquisition Corporation, and Cellu Paper Holdings, Inc.,
which was June 12, 2006 (the “Effective Date”); 
 WHEREAS, the Company anticipates completing an initial public
offering of the common stock of the Company as described in the Registration Statement on Form S-1 (No. 333-162543) (the “Registration Statement”) filed with the Securities and Exchange Commission on October 16, 2009, as amended from
time to time (the “IPO”); 
 WHEREAS, in connection with the IPO, the Company and the Executive desire to amend the
Employment Agreement as set forth in this Amendment effective upon the consummation of the IPO; 
 NOW, THEREFORE, in
consideration of the foregoing premises and the terms set forth in this Amendment, the parties hereby agree as follows effective upon the consummation of the IPO: 
 1. The initial term of the Employment Agreement as set forth in Section 2 of such agreement (which would have expired on June 12, 2010) is hereby extended through June 12, 2011. Except for
this one year extension, the provisions of Section 2 of the Employment Agreement shall continue in full force and effect. 
 2. Section 4(b) of the Employment Agreement is hereby deleted and replaced with the following provision: 
 Executive shall be eligible to receive an annual bonus. Commencing with the 2011 fiscal year, the annual bonus shall be determined by the Compensation Committee of the Board (or a subcommittee of the Compensation Committee) based upon the
Executive’s achievement of performance goals established by such committee, and such annual bonus shall at all times be subject to the terms of the Company’s Annual Executive Bonus Program, as amended from time to time. 
 IN WITNESS WHEREOF, the Company and the Executive have executed this Amendment this 18 day of January, 2010. 
  

									
	CELLU TISSUE HOLDINGS, INC.	 		 		 	EXECUTIVE
					
	By:	 	/s/ W. Edwin Litton	 		 		 	/s/ Steven Ziessler

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}]]